Zhejiang Huaye Plastics Machinery
301616
Alnera Aluminium
301613
Tibet Duo Rui Pharmaceutical
301075
4
ChengDu Sheng Nuo Biotec
688117
5
Guangzhou Sie Consulting
300687
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 17.61%9.74B | 25.15%2.71B | 9.66%2.53B | 41.59%2.54B | -2.84%1.95B | -25.25%8.28B | -12.34%2.17B | -20.06%2.31B | -41.06%1.8B | -24.77%2.01B |
Operating revenue | 17.61%9.74B | 25.15%2.71B | 9.66%2.53B | 41.59%2.54B | -2.84%1.95B | -25.25%8.28B | -12.34%2.17B | -20.06%2.31B | -41.06%1.8B | -24.77%2.01B |
Cost of revenue | 34.13%5.44B | 52.75%1.61B | 28.42%1.43B | 47.17%1.38B | 7.18%1.02B | -15.93%4.05B | -8.01%1.06B | -17.38%1.11B | -25.58%937M | -11.25%947M |
Gross profit | 1.77%4.3B | -1.08%1.1B | -7.78%1.1B | 35.51%1.16B | -11.78%936M | -32.42%4.23B | -16.09%1.11B | -22.39%1.2B | -51.96%859M | -33.77%1.06B |
Operating expense | 26.93%1.1B | 34.00%268M | -18.35%227M | 39.18%270M | 41.05%323M | -25.92%869M | -42.69%200M | 1.09%278M | -23.02%194M | -9.13%229M |
Selling and administrative expenses | 5.98%372M | 36.00%102M | -33.81%92M | 18.06%85M | 43.08%93M | -27.33%351M | -55.62%75M | 101.45%139M | -19.10%72M | -58.33%65M |
-General and administrative expense | 5.98%372M | 36.00%102M | -33.81%92M | 18.06%85M | 43.08%93M | -27.33%351M | -55.62%75M | 101.45%139M | -19.10%72M | -58.33%65M |
Other taxes | 30.43%270M | 47.73%65M | 14.75%70M | 56.00%78M | 9.62%57M | -22.76%207M | 15.79%44M | -25.61%61M | -35.90%50M | -25.71%52M |
Other operating expenses | 48.23%461M | 24.69%101M | -16.67%65M | 48.61%107M | 54.46%173M | -26.30%311M | -42.96%81M | -37.10%78M | -15.29%72M | 330.77%112M |
Operating profit | -4.73%3.2B | -8.78%831M | -4.58%876M | 34.44%894M | -26.32%613M | -33.92%3.36B | -6.56%911M | -27.49%918M | -56.71%665M | -38.37%832M |
Net non-operating interest income expense | -14.33%-367M | -18.18%-91M | -23.46%-100M | -21.95%-100M | 6.17%-76M | -2.88%-321M | -1.32%-77M | -8.00%-81M | -7.89%-82M | 4.71%-81M |
Non-operating interest income | 20.00%12M | 33.33%4M | 0.00%2M | 0.00%3M | 50.00%3M | 0.00%10M | 50.00%3M | 100.00%2M | 0.00%3M | -50.00%2M |
Non-operating interest expense | 14.07%373M | 17.72%93M | 23.17%101M | 20.24%101M | -4.88%78M | 4.14%327M | 1.28%79M | 9.33%82M | 13.51%84M | -5.75%82M |
Total other finance cost | 50.00%6M | 100.00%2M | 0.00%1M | 100.00%2M | 0.00%1M | -50.00%4M | --1M | 0.00%1M | -80.00%1M | -50.00%1M |
Other net income (expense) | -742.21%-1.3B | 18.37%-240M | -27,800.00%-1.12B | 14.53%134M | -252.54%-90M | -115.98%-154M | -203.09%-294M | 78.95%-4M | 5,750.00%117M | -94.29%59M |
Gain on sale of security | -150.44%-283M | 15.67%-183M | ---10M | -139.22%-20M | -232.08%-70M | 58.30%-113M | -63.16%-217M | ---- | 259.38%51M | 185.48%53M |
Special income (charges) | -1,608.47%-1.01B | -38.89%-25M | -28,000.00%-1.12B | 474.42%161M | -433.33%-20M | -105.43%-59M | -260.00%-18M | -114.81%-4M | -43.33%-43M | -99.45%6M |
-Less:Restructuring and merger&acquisition | 1,020.00%168M | 200.00%12M | 180.00%14M | 5,650.00%115M | 575.00%27M | -42.31%15M | -20.00%4M | 25.00%5M | -33.33%2M | -71.43%4M |
-Less:Other special charges | ---- | ---- | ---- | ---- | ---- | -113.43%-9M | --0 | ---- | ---- | -113.43%-9M |
-Write off | 1,750.82%1.13B | 20.00%18M | --1.11B | --0 | ---- | --61M | --15M | --0 | --46M | ---- |
-Gain on sale of business | 3,512.50%289M | 400.00%5M | 0.00%1M | 5,420.00%276M | 600.00%7M | -99.32%8M | --1M | -96.77%1M | 118.52%5M | -99.91%1M |
Other non- operating income (expenses) | -133.33%-6M | 45.76%-32M | --18M | -106.42%-7M | ---- | -87.84%18M | -243.90%-59M | ---- | 70.31%109M | ---- |
Income before tax | -46.76%1.54B | -7.41%500M | -140.82%-340M | 32.57%928M | -44.81%447M | -49.72%2.88B | -32.67%540M | -28.92%833M | -52.12%700M | -64.75%810M |
Income tax | 228.70%417M | 105.66%75M | -172.30%-201M | 29.41%308M | -51.45%235M | -119.61%-324M | -603.42%-1.32B | -56.70%278M | -39.75%238M | 37.50%484M |
Net income | -65.14%1.12B | -77.20%425M | -125.05%-139M | 34.20%620M | -34.97%212M | -21.44%3.21B | 245.83%1.86B | 4.72%555M | -56.70%462M | -83.25%326M |
Net income continuous Operations | -65.14%1.12B | -77.20%425M | -125.05%-139M | 34.20%620M | -34.97%212M | -21.44%3.21B | 245.83%1.86B | 4.72%555M | -56.70%462M | -83.25%326M |
Minority interest income | -10.80%314M | -21.98%71M | -12.50%84M | -2.47%79M | -4.76%80M | -26.36%352M | -5.21%91M | -11.11%96M | -42.55%81M | -36.84%84M |
Net income attributable to the parent company | -71.84%804M | -80.03%354M | -148.58%-223M | 41.99%541M | -45.45%132M | -20.78%2.86B | 300.23%1.77B | 8.77%459M | -58.86%381M | -86.65%242M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | 0 | 0 | ||||||||
Net income attributable to common stockholders | -71.84%804M | -80.03%354M | -148.58%-223M | 41.99%541M | -45.45%132M | -22.29%2.86B | 300.23%1.77B | 8.77%459M | -58.86%381M | -87.15%242M |
Basic earnings per share | -75.38%2.28 | -83.42%0.96 | -140.27%-0.6 | 17.74%1.46 | -43.59%0.44 | -16.20%9.26 | 319.57%5.79 | 16.41%1.49 | -54.41%1.24 | -85.66%0.78 |
Diluted earnings per share | -75.46%2.27 | -83.39%0.96 | -140.27%-0.6 | 18.70%1.46 | -43.59%0.44 | -16.06%9.25 | 318.84%5.78 | 16.41%1.49 | -54.61%1.23 | -85.64%0.78 |
Dividend per share | 0.00%1 | 0.00%0.25 | 0.00%0.25 | 0.00%0.25 | 0.00%0.25 | 60.00%1 | 0.00%0.25 | 100.00%0.25 | 100.00%0.25 | 100.00%0.25 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |